Nuclear factor of activated T cells-family proteins (NFAT1/NFATp, NFATc, NFAT3, and NFAT4/NFATx/NFATc3) play a key role in the transcription of cytokine genes and other genes during the immune response. We have defined the mechanisms of transactivation by NFAT1. NFAT1 possesses two transactivation domains whose sequences are not conserved in the other NFAT-family proteins, and a conserved DNA-binding domain that mediates the recruitment of cooperating nuclear transcription factors even when it is expressed in the absence of other regions of the protein. The activity of the NH2-terminal transactivation domain is modulated by an adjacent regulatory region that contains several conserved sequence motifs represented only in the NFAT family. Our results emphasize the multiple levels at which NFAT-dependent transactivation is regulated, and predict significant differences in the architecture of cooperative transcription complexes containing different NFAT-family proteins.
T
he nuclear factor of activated T cells (NFAT) 1 is a calcium-regulated transcription factor that is a major target for the immunosuppressive drugs cyclosporin A (CsA) and FK506 (1) (2) (3) . The DNA-binding specificity of NFAT is conferred by a novel family of transcription factors, of which four members (NFAT1/NFATp, NFATc, NFAT3, and NFATx/NFAT4/NFATc3, each containing several isoforms) have so far been described (4) (5) (6) (7) (8) (9) . NFAT1 protein is expressed in several classes of immune system cells (10) (11) (12) , consistent with the detection of nuclear NFAT DNA-binding activity in activated T, B, mast, and NK cells (13) (14) (15) (16) (17) (18) (19) . The distribution of the other NFAT-family proteins has not yet been assessed at the protein level; however the mR.NAs encoding these proteins differ in their cell and tissue distributions and their representation in resting versus activated cells (5) (6) (7) , suggesting that each protein may subserve a different function. NFATc mlLNA is expressed at high levels in skeletal muscle and in activated lymphoid cells, NFATx/ NFAT4 mP,.NA is predominantly expressed in the thymus, and NFAT3 mR.NA is most strongly expressed outside the immune system (5) (6) (7) .
An important component of transactivation by NFATfamily proteins is their cooperation in the nucleus with Fos and Jun (20, 21) . This cooperation is mediated by interac1Abbreviations used in this paper: CAT, chloramphenicol acetyltransferase; CsA, cyclosporin A; DBD, DNA-binding domain; hGH, human growth hormone; NFAT, nuclear factor of activated T cells; NHP,., NFAT homology region; TAD, transactivation domain. tion of the highly conserved DNA-binding domains (DBDs) of NFAT-family proteins with Fos-Jun and Jun-Jun dimers (6, 7, 22) ; the bZIP (basic region-leucine zipper) regions of Fos and Jun suffice for this interaction (21) , although an acidic region of Fos has also been implicated (23) . Overexpression of Fos-and Jun-family proteins in T cells greatly augments transcription driven by tandem copies of the IL-2 and IL-4 promoter NFAT sites in activated T cells (20, (24) (25) (26) . It has also been suggested that NFAT-family proteins are able to act independently or cooperate with transcription factors of the GATA family (18, 27) . We asked whether NFAT-family proteins contain intrinsic transactivation domains (TADs), or whether they function by recruiting other transcription factors.
Here we define the mechanisms of transactivation by NFAT1. We show that NFAT1 contains two intrinsic TADs at its NH 2-and COOH-terminal ends that are not represented in the other NFAT-family proteins. The activity of the NH2-terminal TAD is regulated by the adjacent NFAT homology region (NHR), a serine-and proline-rich region that contains several sequence motifs conserved within the NFAT family. We also show that the conserved DBD of NFAT1 contributes potently to transactivation at composite NFAT sites, since it is capable of recruiting cooperating transcription factors even when expressed independently of the other regions ofNFAT1. Our results suggest that NFATdependent transactivation involves a common mechanism mediated by the conserved DBD, as well as unique mechanisms involving the nonconserved TADs.
Materials and Methods
Transfections. Jurkat cells were transfected with 2-5 ~g of expression and reporter plasmids, subdivided equally into identical cultures, incubated for 18-24 h at 37~ and then stimulated overnight with 1 p~M ionomycin, 10 nM PMA, or both in the absence or presence of 1 p~M CsA (added 30 min before the stimuli). Cells were harvested 18-24 h later, and cell extracts were assayed for chloramphenicol acetyltransferase (CAT) or luciferase activity as described (8) . When the percent conversion of CAT assay was either very high or very low, the assay was repeated with an adjusted amount of cell lysate to ensure a linear range. Transfection efl~ciencies were determined by measuring human growth hormone (hGH) expression from a cotransfected RSVhGH plasmid (0.5 p~g), and protein concentration was determined by Bradford assay (Bio-Rad Laboratories, Hercules, CA).
GAL4 Plasmids. GAL4-NFAT1(1-415) was constructed by replacing the E2F fragment of GAL4-E2F (28) between the BamHI and XbaI sites with the 1,264-bp fragment of human NFAT1 cDNA (8) , from the BssHlI site to the EcoRl site in the polylinker ofpBluescript. It encodes amino acids 1-415 of NFAT1 in frame with the GAL4 DBD (amino acids 1-147). The GAL4-NFAT1(57-415), GAL4-NFATl(145-415), GAL4-NFAT1(259-415), GAL4-NFAT1ASP1, GAL4-NFAT1ASP2, and GAL4-N FAT 1ASS plasmids were made by excising appropriate restriction fragments from GAL4-NFAT1(1-415) and religating the plasmids. The COOH-terminally deleted plasmids, GAL4-NFAT1 (1-293), GAL4-NFATl(1-230), and GAL4-NFAT1(1-171) were made by replacing the BamHI-XbaI E2F fragment from GAL4-E2F with the appropriate restriction fragments of NFAT1. The chimeras encoded by GAL4-NFATl(1-415), GAL4-NFAT1(1-293), GAL4-NFAT1(1-230), GAL4-NFAT1(1-171), GAL4-NFATIASP1, GAL4-NFAT1ASP2, and GAL4-NFAT1ASS have a linker with the sequence PEFPAGDR.IRA between the GAL4 DBD and NFAT1 sequences. GAL4-NFATl(57-415) has a linker of PEFPA, and the other NH2-terminal deletions have a linker of PEFP. Except for GAL4-NFATl(1-293), GAL4-NFAT1(1-230), and GAL4-NFATl(1-171), all other constructs have an extra sequence of PRAEF before the stop codon. GAL4-NFAT1(727-927) was constructed by replacing the NFAT1(1-415) fragment between the SmaI and Xbal sites in GAL4-hNFAT1(1-415) with the NcoIHindlII fragment from pLGP-mNFAT1-C (8) . It has a linker of PEFP between the GAL4 DBD and the routine NFAT1 sequence. GAL4-BB-E2F was constructed by replacing the BamHI-Xbal fragment of GAL4-NFAT1(57-415) with the XmaI-XbaI fragment of E2F of GAL4-E2F. It has a linker of PGI between NFAT1 (amino acids 57-318) and E2F. The GAL4-E2F, RSV-GAL4DBD, RSV-CAT, and the reporter CAT plasmid with three GAL4 DNA-binding sites (28) were gifts from Dr. Erik K. Flemington (Dana-Farber Cancer Institute, Boston, MA).
NFA T1 Expression Plasmids. The pEFTAG, pLGP-mNFAT1-C, and pEFTAG-mNFAT1-C expression plasmids have been described (8) . The pEFTAG-NFATl(1-415) plasmid was made by subcloning the XmaI-XbaI fragment of GAL4-NFAT1 into pEFTAG between the Not1 and XbaI sites. The pEFTAG-NFATIAN plasmid, which encodes amino acids 399-927 ofmufine NFAT1-C, was constructed by subcloning the XhoI-XbaI fragment of pEFTAG-mNFAT1-C into pEFTAG between the Not1 and XbaI sites. The pEFTAG-NFATIDBD and pEFTAGNFAT1DBDn expression plasmids, which encode amino acids 398-694 and 398-584 ofmurine NFATI, respectively, were constructed by subcloning the KpnI-BlpI fragment of NFATpXS(1-297) and NFATpXS(1-187) (22) into the NotI site ofpEFTAG.
Reporter Plasmids. The pBLCAT5/NFAT3X reporter plas-142 mid has been described (8) . The pBLCAT5/NFAT(M3)3X and pBLCAT5/NFAT(M4)3X reporter plasmids were made by replacing the trimer of NFAT sites in pBLCAT5/NFAT3X with trimers of NFAT(M3) and NFAT(M4) (22) , respectively. The NFAT3X-Luc and 5'IL2-Luc plasmids were kind gifts from Dr. David McKean (Mayo Clinic, Rochester, MN).
Results and Discussion
We assessed the intrinsic transactivation potential of the NH 2-and COOH-terminal regions of NFAT1, that flank the centrally located DBD, by testing chimeric proteins in which amino acids 1-415 and 727-927 of NFAT1 were fused to the COOH terminus of the heterologous DBD of GAL4. Both regions have features resembling TADs: the NH2-terminal region is acidic and proline rich, whereas the COOH-terminal region is glutamine and proline rich (8) . When expressed in Jurkat T cells, both chimeric proteins were capable of transactivation, provided that the reporter plasmid contained GAL4 binding sites ( When cells expressing the GAL4-NFATI(1-415) chimeric protein were stimulated with the calcium ionophore, ionomycin, GAL4-dependent transactivation was reproducibly enhanced (Fig. 1 B, lanes 1 and 2; 2.0 + 0.4-fold, n = 8). Stimulation with PMA alone had no effect (lane 3; 0.8 + 0.1-fold, n = 3), and stimulation with PMA plus ionomycin did not increase the level of CAT activity over that observed with ionomycin alone (lane 4; 2.5 -0.9-fold, n = 3). Notably, CsA completely blocked the ionomycin-induced increase in CAT activity mediated by the GAL4-NFAT1(1-415) chimeric protein (Fig. 1 B; lanes 5-8). CsA did not block the basal level of transactivation mediated by this protein in unstimulated Jurkat cells, indicaring that CsA does not suppress the transcriptional function of the chimera per se. Transactivation by the GAL4-NFAT1(727-927) chimeric protein was not affected by ionomycin, PMA, or CsA (data not shown), indicating that although both the NH2-and COOH-terminal regions of NFAT1 possessed transactivating function, only the activity of the NH2-terminal region of NFAT1 was capable of being regulated in a calcium-and calcineurin-dependent fashion. The lack of effect of PMA on the transactivation activities of these chimeras suggests that the intrinsic transactivation activity of NFAT1 is not regulated by PMAstimulated signaling pathways.
The (1-415) region of NFAT1 contains a unique region (amino acids 1-~100) not represented in the other NFATfamily proteins, as well as an adjacent ~300-amino acid NHR (amino acids ~100--~380) that shows a moderate level of sequence conservation within the NFAT family Relative CAT activities (mean + SD, n ~ 3) shown are CAT activities normalized to that ofunstimulated cells transfected with GAL4-hNFAT1(1-415). Fold induction is shown where there is significant difference between CAT activities of unstimulated and ionomycin stimulated cells (P ~0.02). (8) . Detailed inspection of the NHR reveals the presence of several strongly conserved sequence motifs (8) , including three repeats of the SP motifs (6) (consensus sequence,
SPxxSPxxSPxxxxx[D/E][D/E]).
To localize the regions within the GAL4-NFAT1(1-415) protein required for transactivation and regulation by ionomycin, we tested GAL4 chimeric proteins containing NH 2-or COOH-terminally deleted derivatives of the NFATl(1-415) fragment (Fig. 1 C) . These proteins were expressed in Jurkat cells with the GAL4-CAT reporter plasmid. Deletion of as few as 57 residues from the NH2 terminus of NFAT1 abolished transactivation (Fig. 1 C, row 3) , and further NH2-terminal deletions did not restore function (rows 4 and 5). In contrast, chimeric proteins containing deletions of up to 185 residues from the COOH terminus of the 1-415 region ( Fig. 1 C, rows 6-10) retained the ability to mediate transactivation. The low basal activities of proteins containing the NH2-terminal half of the NHP, (Fig. 1 C, rows 6-8) were likely due to their low level of expression, since increasing the amount ofplasmid DNA in transfections led to higher basal activities (data not shown); however their transactivation activities were clearly augmented in ionomycinstimulated cells (row 6-8). Deletions of most of the NHR.
( Fig. 1 C, rows 9 and 10 ), or the NH2-terminal half of the NHP, (row 11), resulted in high basal activities that were not further increased by stimulation with ionomycin, even when the amount ofplasmid DNA used in the transfection was titrated to yield a lower basal level of CAT activity (data not shown).
These results indicated that the NH2-terminal region of NFAT1 contains a strong TAD encoded within amino acids 1-144. However, the activity of this TAD is fully revealed only in the absence of amino acids 145-387, which constitute essentially all of the NHR. In the presence of the NHP,, moreover, the activity of the NH2-terminal TAD of NFAT1 was regulated in a calcium/calcineurin-dependent manner. Indeed, we found that the NH1L was capable of conferring a small degree ofionomycin responsiveness on an unrelated protein, since transactivation by a chimeric protein (GAL4-BB-E2F), in which amino acids 57-318 of NFAT1 were introduced between the GAL4 DBD and the E2F TAD, was significantly stimulated by ionomycin treatment of Jurkat cells (1.65 + 0.1-fold induction, n = 6, P <0.001). CsA pretreatment reproducibly blocked the ionomycinmediated stimulation (1.02 + 0.32-fold induction, n = 6), but did not affect the basal level of transactivation. The level of transactivation by the parent GAL4-E2F chimera was unaffected by ionomycin stimulation (0.96 -+-+ 0.2-fold induction, n = 3).
We compared the transactivation functions of full-length NFAT1 with those of NFAT1(399-927) (here termed NFATIAN), which lacks the NH2-terminal TAD and NHR. Expression of either protein in Jurkat T cells resulted in increased basal transactivation of a CAT reporter plasmid containing three copies of the NFAT site of the routine IL-2 promoter. As expected, further induction of CAT activity by full-length recombinant NFAT1 required stimulation with both ionomycin and PMA, and was completely inhibited by pretreatment with CsA (Fig. 2, left) . In contrast, transactivation by NFAT1AN was stimulated by PMA alone and was not inhibited by pretreatment with CsA (Fig. 2, right) .
We have previously shown that full-length NFAT1 is cytoplasmic in resting T cells and translocates into the nucleus upon ionomycin stimulation (8) , whereas NFAT1AN is diffusely distributed throughout the nucleus and the cytoplasm in both resting and stimulated cells (29) . Thus, the results shown in Fig. 2 indicate that nuclearly localized NFAT1 and NFAT1AN require PMA for optimal transactivation, whereas ionomycin is required only for translocation of full-length NFAT1 into the nucleus. Given that PMA does not stimulate the activity of the intrinsic TADs of NFAT1 (see above), we postulated that the PMA requirement for transactivation most likely reflected the requirement for cooperation of NFAT1 with PMA-stimulated transcription factors such as Fos andJun (1).
To evaluate the contribution of cooperating nuclear proteins to NFATl-dependent transcription, we tested whether the DBD of NFAT1 (which is sufficient for cooperation with Fos and Jun proteins; 22) could independently mediate transactivation. Expression of NFAT1DBD (amino acids 398-694 of murine NFAT1) caused transactivation of a hiciferase reporter plasmid containing three tandem NFAT sites (NFAT3X-Luc) in unstimulated Jurkat T cells, and stimulation with PMA plus ionomycin greatly increased the level of transactivation (Fig. 3 A, left) . This effect is probably not due to an intrinsic transactivation function possessed by the DBD, since a longer fragment of NFAT1 containing the NFAT1DBD does not show transactivation activity in vitro (4). The effect is striking because isolated DNA-binding fragments of other transcription factors usually inhibit transactivation when overexpressed, most likely by competing for endogenous dimerization partners and/or blocking the relevant sites on DNA (30, 31) . NFAT1DBD contains the region corresponding to both the NH2-temfinal specificity subdomain and the COOH-terminal dimerization domain of p50 NF-KB (32, 33) . However the smallest fragment of NFAT1 capable of DNA binding and cooperative interaction with Fos andJun is a shorter 187-amino acid fragment (NFATIDBDn, amino acids 398-584 of murine NFAT1) that corresponds to the NH2-terminal specificity subdomain of p50 NF-r,.B (32, 33) . Strikingly, NFATIDBDn was also able to mediate the inducible transcription of NFAT3X-Luc in Jurkat T cells (Fig. 3 A,  left) . Moreover, both NFATIDBD and NFAT1DBDn increased the transcription of a luciferase reporter gene controlled by the IL-2 promoter (Fig. 3 A, right) . In this case, the increased transcription was apparent in stimulated but not in unstimulated Jurkat T cells, presumably because other inducible transcription factors such as NF-KB are required for IL-2 promoter induction (3).
The binding of NFAT1DBD and NFATIDBDn to the composite NFAT site of the IL-2 promoter is greatly stabilized in the presence ofFos andJun (20) . To test whether the transcriptional activation observed to be mediated by these fragments was due to AP-1 proteins recruited to the composite site, we used CAT reporter plasmids containing mutated NFAT sites. The M3 mutation of the NFAT site of the IL-2 promoter abrogates the binding of NFAT proteins and their recruitment of AP-1 proteins, whereas the M4 mutation permits the binding of NFAT proteins but prevents the formation of the NFAT-Fos-Jun complex (22, 34) . Both the M3 and M4 mutations severely compromised transactivation by N F A T I D B D and NFAT1DBDn (Fig.  3 B) . Western analysis of the epitope-tagged NFATIDBD confirmed that it was expressed equivalently in each transfection (data not shown). These results indicated that transactivation by NFATIDBD and NFATIDBDn required DNA binding by the NFAT1 fragments and recruitment of AP-1 proteins or other cooperating transcription factors to the adjacent AP-1 site, and was unlikely to involve other mechanisms such as squelching or titrating a repressor. Taken together, these results indicate that transactivation by NFAT-family proteins is regulated at multiple levels. The strongly conserved DBDs operate even in the absence of intrinsic TADs to mediate transcription via cooperating factors recruited to composite sites. The minimal 187-amino acid DBD suffices for this effect, emphasizing the remarkable specialization of NFAT-family proteins for cooperative interactions on DNA. The DBDs of GATA and MyoD1 are sufficient to induce cell differentiation (35, 36) , suggesting that the use of DBDs of transcription factors as docking sites for recruiting other transactivating factors may be a general mechanism of transactivation. NFAT1 also contains two intrinsic TADs that are not conserved within the NFAT family: indeed, the region corresponding to the COOH-terminal TAD of NFAT1 is missing in NFATc and in the shorter isoforms of NFAT4 (5-9). Finally, the conserved N H R appears to repress the activity of the NH2-terminal TAD, since its removal greatly enhances transactivation mediated by the unique NH2-terminal region.
Our results are consistent with the hypothesis that the N H R of NFAT1 controls the subcellular localization of this protein, which is known to be regulated by a calciumand calcineurin-dependent pathway (10). Removal of the N H R or the entire NH2-terminal region from NFAT1 abrogates its regulated subcellular localization in resting and stimulated T cells (29) , and transactivation by the truncated protein NFATIAN is no longer sensitive to ionomycin or CsA. Despite the presence of a strong nuclear localization signal in the GAL4 DBD, GAL4 chimeras containing the N H R also show significant responsiveness to ionomycin and CsA. One hypothesis is that the presence of the N H R alters the nuclear-to-cytoplasmic ratio of these GAL4 chimeric proteins in a calcineurin-dependent manner. Alternatively, calcineurin may regulate the ability of the N H R to mask the transactivation properties of the strong NH2-terminal TAD ofNFAT1. In either case, the N H R is likely to be a major target for calcineurin within NFAT1, and in fact we have shown that fragments containing the NHRs of both NFAT1 and NFATc bind calcineurin directly (29, 37) . The conserved sequences of the NHRs of NFATfamily proteins suggest that NHR may contribute to the CsA-sensitive response to ionomycin stimulation of all NFAT-family members, and the variation in NH1Ls of NFAT-family proteins could account for their different behavior in resting cells.
Although there is no clearcut conservation of sequence, the NH/-terminal ,"~100 residues of NFAT1, NFAT3, and NFAT4 are each rich in acidic residues and proline (5) (6) (7) (8) , and contain acid hydrophobic patches characteristic of acidic TADs (8, 38, 39) . In contrast, the NH2-terminal region of NFATc (which is also capable of transactivation; Luo, C., unpublished data) is proline rich but not acidic. Thus transactivation by the different NFAT-family proteins may be mediated by distinct interactions of the different TADs with coactivators, TATA, binding protein-associated factors (TAFs), and other components of the basal transcription machinery (40) . In conjunction with the distinct site preferences of NFAT-family proteins (7, 9) and the diverse sequences and arrangements of NFAT sites in inducible promoter/enhancer regions (1), such interactions may determine the cell-specific expression ofcytokine genes.
